These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

336 related items for PubMed ID: 15311054

  • 1. A side by side comparison of cytology and biomarkers for bladder cancer detection.
    Schroeder GL, Lorenzo-Gomez MF, Hautmann SH, Friedrich MG, Ekici S, Huland H, Lokeshwar V.
    J Urol; 2004 Sep; 172(3):1123-6. PubMed ID: 15311054
    [Abstract] [Full Text] [Related]

  • 2. Immunocyt and the HA-HAase urine tests for the detection of bladder cancer: a side-by-side comparison.
    Hautmann S, Toma M, Lorenzo Gomez MF, Friedrich MG, Jaekel T, Michl U, Schroeder GL, Huland H, Juenemann KP, Lokeshwar VB.
    Eur Urol; 2004 Oct; 46(4):466-71. PubMed ID: 15363562
    [Abstract] [Full Text] [Related]

  • 3. Four bladder tumor markers have a disappointingly low sensitivity for small size and low grade recurrence.
    Boman H, Hedelin H, Holmäng S.
    J Urol; 2002 Jan; 167(1):80-3. PubMed ID: 11743280
    [Abstract] [Full Text] [Related]

  • 4. Comparative evaluation of the diagnostic performance of the BTA stat test, NMP22 and urinary bladder cancer antigen for primary and recurrent bladder tumors.
    Giannopoulos A, Manousakas T, Gounari A, Constantinides C, Choremi-Papadopoulou H, Dimopoulos C.
    J Urol; 2001 Aug; 166(2):470-5. PubMed ID: 11458049
    [Abstract] [Full Text] [Related]

  • 5. A comparison of BTA stat, hemoglobin dipstick, telomerase and Vysis UroVysion assays for the detection of urothelial carcinoma in urine.
    Halling KC, King W, Sokolova IA, Karnes RJ, Meyer RG, Powell EL, Sebo TJ, Cheville JC, Clayton AC, Krajnik KL, Ebert TA, Nelson RE, Burkhardt HM, Ramakumar S, Stewart CS, Pankratz VS, Lieber MM, Blute ML, Zincke H, Seelig SA, Jenkins RB, O'Kane DJ.
    J Urol; 2002 May; 167(5):2001-6. PubMed ID: 11956427
    [Abstract] [Full Text] [Related]

  • 6. [Usefulness of BTA Stat test (Bard) in the diagnosis of bladder cancer. Preliminary results and comparison with cytology and cystoscopy].
    Gutiérrez Baños JL, Martín García B, Hernández Rodríguez R, Portillo Martín JA, Correas Gómez MA, del Valle Schaan JI, Roca Edreira A, Villanueva Peña A, Gutíerrez García R, De Diego Rodríguez E, Rado Velázquez MA.
    Arch Esp Urol; 1998 Oct; 51(8):778-82. PubMed ID: 9859583
    [Abstract] [Full Text] [Related]

  • 7. Comparison of screening methods in the detection of bladder cancer.
    Ramakumar S, Bhuiyan J, Besse JA, Roberts SG, Wollan PC, Blute ML, O'Kane DJ.
    J Urol; 1999 Feb; 161(2):388-94. PubMed ID: 9915409
    [Abstract] [Full Text] [Related]

  • 8. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
    Eissa S, Swellam M, Sadek M, Mourad MS, El Ahmady O, Khalifa A.
    J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289
    [Abstract] [Full Text] [Related]

  • 9. Routine follow-up cystoscopy in detection of recurrence in patients being monitored for bladder cancer.
    Raitanen MP, Leppilahti M, Tuhkanen K, Forssel T, Nylund P, Tammela T, FinnBladder Group.
    Ann Chir Gynaecol; 2001 Aug; 90(4):261-5. PubMed ID: 11820414
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Clinical value of combined detection with urinary bladder cancer antigen, hyaluronic acid and cytokeratin 20 in diagnosis of bladder cancer].
    Pu XY, Wang ZP, Chen YR, Wu YL, Wang HP, Wang XH.
    Ai Zheng; 2008 Sep; 27(9):970-3. PubMed ID: 18799038
    [Abstract] [Full Text] [Related]

  • 12. Results of Bard BTA test in monitoring patients with a history of transitional cell cancer of the bladder.
    Ianari A, Sternberg CN, Rossetti A, Van Rijn A, Deidda A, Giannarelli D, Pansadoro V.
    Urology; 1997 May; 49(5):786-9. PubMed ID: 9145993
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Comparative study of BTA stat test, NMP-22, and cytology in the diagnosis of bladder cancer].
    Gutiérrez Baños JL, Rebollo Rodrigo MH, Antolín Juarez F, Martín García B, Hernández Rodríguez R, Portillo Martín JA, Correas Gómez MA, del Valle Schaan JI, Roca Edreira A, de Diego Rodríguez E, Radó Velázquez MA.
    Arch Esp Urol; 2000 May; 53(1):21-7. PubMed ID: 10730421
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Noninvasive detection of bladder cancer with the BTA stat test.
    Pode D, Shapiro A, Wald M, Nativ O, Laufer M, Kaver I.
    J Urol; 1999 Feb; 161(2):443-6. PubMed ID: 9915422
    [Abstract] [Full Text] [Related]

  • 19. Neural network using combined urine nuclear matrix protein-22, monocyte chemoattractant protein-1 and urinary intercellular adhesion molecule-1 to detect bladder cancer.
    Parekattil SJ, Fisher HA, Kogan BA.
    J Urol; 2003 Mar; 169(3):917-20. PubMed ID: 12576812
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.